FDA to Study Potential Treatment for CFD-Related Autism In line with its new commitment to finding the root causes of autism and treatments for it, the FDA is working with GSK, innovator of Wellcovorin (leucovorin calcium), to broaden the approval of leucovorin calcium tablets for patients with cerebral folate deficiency (CFD), a neurological condition that affects folate (a vitamin essential for brain health) transport into the brain
Patients who frequently forget doses should consider setting reminders or alarms and should discuss adherence strategies with their healthcare provider to maintain consistent dosing
Potential role of Plasmodium falciparum exported protein 1 in the chloroquine mode of action
Ask about expected magnitude of weight loss, likely side effects, monitoring needs and durability
Hemophagocytic Lymphohistiocytosis (HLH) In April 2018, the FDA issued a safety warning about hemophagocytic lymphohistiocytosis, a rare but potentially fatal immune system reaction linked to Lamictal use